Samraat S. Raha is Chief Operating Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 481,240 shares of MYGN, which is worth approximately $4.78 Million. The most recent transaction as insider was on Mar 14, 2025, when has been sold 7,649 shares (Common Stock) at a price of $10.07 per share, resulting in proceeds of $77,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 481K
76.67% 3M change
59.96% 12M change
Total Value Held $4.78 Million

Samraat S. Raha Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2025
SELL
Payment of exercise price or tax liability
$77,025 $10.07 p/Share
7,649 Reduced 1.56%
481,240 Common Stock
Mar 13 2025
BUY
Grant, award, or other acquisition
-
216,495 Added 30.69%
488,889 Common Stock
Dec 11 2024
SELL
Payment of exercise price or tax liability
$429,176 $14.51 p/Share
29,578 Reduced 9.79%
272,394 Common Stock
Nov 30 2024
BUY
Grant, award, or other acquisition
$15,461 $13.83 p/Share
1,118 Added 0.37%
301,972 Common Stock
Mar 14 2024
BUY
Grant, award, or other acquisition
-
64,494 Added 17.65%
300,854 Common Stock
Dec 11 2023
BUY
Grant, award, or other acquisition
-
236,360 Added 50.0%
236,360 Common Stock

Also insider at

A
AGILENT TECHNOLOGIES, INC. Healthcare
SSR

Samraat S. Raha

Chief Operating Officer
Santa Clara, CA

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN